Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Mucocele in New Zealand
Total 0 results
Nothing found
Sponsors and Collaborators
Seed Health
French National Society of Gastroenterology
Zhengzhou First People's Hospital
Chengdu Integrated TCM&Western Medicine Hospital
Intermed Hospital
Bioraba
CEVAC Core Lab, University Ghent
Klinikum Freising
ATTRaCT program by A*STAR BMRC Singapore
Sysmex Inostics GmbH
Kyongtae Ty Bae, M.D., Ph.D.
African Institute for Health and Development
Jennifer King
Menzis
R.Bos
Meyer Children's Hospital, Florence, Italy
metaMe Health
Creighton University
Chul Kim
Brandeis University
View Full List
Medical Conditions
Bacterial Reduction Post-product Application
Root Canal Sealers
Alert Fatigue, Health Personnel
Mild Traumatic Brain Injury; Concussion
Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
Regenerative Periodontal Treatment
Bleeding at Gastric Cancer
Failure; Cardiac
Plaque Type Psoriasis
Chronic Hepatitis C Virus Infection
Value-Based Health Insurance
Early Phase of Severe Sepsis and Septic Shock
Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+)
Adductor Pollicis
Cell Phone Use
Burn Wound and Skin Graft Healing
Hearing Loss, Bilateral or Unilateral
Parenteral Iron Therapy
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma
Systemic Lupus Erythematosus Nephritis
View Full List
Drug Interventions
Fesoterodine
Stem Cell Product
Insulin glargine
Methylphenidate
PF-06650833
Itraconazole
Phase 2a, SQY51 (cohort 3)
Leucovorin
IDP-126 Vehicle Gel
Galantamine CR
Esketamine
Ciclesonide
Soy protein isolate
LFG316 active drug
30 mg CVL-231 Target Release, Fed
0.27 mg/kg, age≥65
Estradiol plus MPA
Bupivacaine 0.5%
Follitropin beta liquid formulation
Nitric Oxide gas at 160ppm
View Full List
CROs by country
Contract Research Organizations in Angola
Contract Research Organizations in Bahamas
Contract Research Organizations in Bahrain
Contract Research Organizations in Croatia
Contract Research Organizations in Ecuador
Contract Research Organizations in Finland
Contract Research Organizations in Kosovo
Contract Research Organizations in Liberia
Contract Research Organizations in Mali
Contract Research Organizations in Nigeria
Contract Research Organizations in Rwanda
Contract Research Organizations in Uruguay
Contract Research Organizations in Zimbabwe
CRO list by country
CROs in Luxembourg
HEMEX AG
SGS
All CROs in Luxembourg
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe